These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 33139933)

  • 1. A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy.
    Xu J; Lv J; Zhuang Q; Yang Z; Cao Z; Xu L; Pei P; Wang C; Wu H; Dong Z; Chao Y; Wang C; Yang K; Peng R; Cheng Y; Liu Z
    Nat Nanotechnol; 2020 Dec; 15(12):1043-1052. PubMed ID: 33139933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Minimalist" Nanovaccine Constituted from Near Whole Antigen for Cancer Immunotherapy.
    Wang K; Wen S; He L; Li A; Li Y; Dong H; Li W; Ren T; Shi D; Li Y
    ACS Nano; 2018 Jul; 12(7):6398-6409. PubMed ID: 29927574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly Enhanced Antitumor Immunity by a Three-Barreled Strategy of the l-Arginine-Promoted Nanovaccine and Gene-Mediated PD-L1 Blockade.
    Hu Y; Lin L; Chen J; Hao K; Zhang S; Guo X; Guo Z; Tian H; Chen X
    ACS Appl Mater Interfaces; 2020 Sep; 12(37):41127-41137. PubMed ID: 32808767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoscale Coordination Polymer Based Nanovaccine for Tumor Immunotherapy.
    Zhao H; Xu J; Li Y; Guan X; Han X; Xu Y; Zhou H; Peng R; Wang J; Liu Z
    ACS Nano; 2019 Nov; 13(11):13127-13135. PubMed ID: 31710460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unprecedented Chiral Nanovaccines for Significantly Enhanced Cancer Immunotherapy.
    Liu H; Xie Z; Zheng M
    ACS Appl Mater Interfaces; 2022 Sep; 14(35):39858-39865. PubMed ID: 36007113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward Personalized Peptide-Based Cancer Nanovaccines: A Facile and Versatile Synthetic Approach.
    Kakwere H; Ingham ES; Allen R; Mahakian LM; Tam SM; Zhang H; Silvestrini MT; Lewis JS; Ferrara KW
    Bioconjug Chem; 2017 Nov; 28(11):2756-2771. PubMed ID: 28956907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitroxide radical conjugated ovalbumin theranostic nanosystem for enhanced dendritic cell-based immunotherapy and T
    Hou Y; Kong F; Tang Z; Zhang R; Li D; Ge J; Yu Z; Wahab A; Zhang Y; Iqbal MZ; Kong X
    J Control Release; 2024 Sep; 373():547-563. PubMed ID: 39059501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanovaccine based on a protein-delivering dendrimer for effective antigen cross-presentation and cancer immunotherapy.
    Xu J; Wang H; Xu L; Chao Y; Wang C; Han X; Dong Z; Chang H; Peng R; Cheng Y; Liu Z
    Biomaterials; 2019 Jul; 207():1-9. PubMed ID: 30947117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A generally minimalist strategy of constructing biomineralized high-efficiency personalized nanovaccine combined with immune checkpoint blockade for cancer immunotherapy.
    Zhang S; Feng Y; Meng M; Li Z; Li H; Lin L; Xu C; Chen J; Hao K; Tang Z; Tian H; Chen X
    Biomaterials; 2022 Oct; 289():121794. PubMed ID: 36113330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical Tumor-Derived Personalized Photothermal Vaccine Formulation for Cancer Immunotherapy.
    Ye X; Liang X; Chen Q; Miao Q; Chen X; Zhang X; Mei L
    ACS Nano; 2019 Mar; 13(3):2956-2968. PubMed ID: 30789699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid-Ionizable Iron Nanoadjuvant Augments STING Activation for Personalized Vaccination Immunotherapy of Cancer.
    Chen F; Li T; Zhang H; Saeed M; Liu X; Huang L; Wang X; Gao J; Hou B; Lai Y; Ding C; Xu Z; Xie Z; Luo M; Yu H
    Adv Mater; 2023 Mar; 35(10):e2209910. PubMed ID: 36576344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanovaccine Incorporated with Hydroxychloroquine Enhances Antigen Cross-Presentation and Promotes Antitumor Immune Responses.
    Liu J; Liu X; Han Y; Zhang J; Liu D; Ma G; Li C; Liu L; Kong D
    ACS Appl Mater Interfaces; 2018 Sep; 10(37):30983-30993. PubMed ID: 30136844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoroalkane modified cationic polymers for personalized mRNA cancer vaccines.
    Li J; Wu Y; Xiang J; Wang H; Zhuang Q; Wei T; Cao Z; Gu Q; Liu Z; Peng R
    Chem Eng J; 2023 Jan; 456():140930. PubMed ID: 36531858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rough Nanovaccines Boost Antitumor Immunity Through the Enhancement of Vaccination Cascade and Immunogenic Cell Death Induction.
    Zhao X; Zhang J; Chen B; Ding X; Zhao N; Xu FJ
    Small Methods; 2023 May; 7(5):e2201595. PubMed ID: 36869418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-Penetrating Peptide Enhanced Antigen Presentation for Cancer Immunotherapy.
    Wu H; Zhuang Q; Xu J; Xu L; Zhao Y; Wang C; Yang Z; Shen F; Liu Z; Peng R
    Bioconjug Chem; 2019 Aug; 30(8):2115-2126. PubMed ID: 31339694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel fluoropolymer as a protein delivery vector with robust adjuvant effect for cancer immunotherapy.
    Zhan YR; He X; Huang ZY; Chen P; Tian MM; Li GH; Yu XQ; Song XR; Zhang J
    J Mater Chem B; 2023 Sep; 11(37):8933-8942. PubMed ID: 37682063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microdosed Lipid-Coated (67)Ga-Magnetite Enhances Antigen-Specific Immunity by Image Tracked Delivery of Antigen and CpG to Lymph Nodes.
    Ruiz-de-Angulo A; Zabaleta A; Gómez-Vallejo V; Llop J; Mareque-Rivas JC
    ACS Nano; 2016 Jan; 10(1):1602-18. PubMed ID: 26678549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells.
    Cao X; Zhang W; Wang J; Zhang M; Huang X; Hamada H; Chen W
    Immunology; 1999 Aug; 97(4):616-25. PubMed ID: 10457215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Cell Membrane-Coated Adjuvant Nanoparticles with Mannose Modification for Effective Anticancer Vaccination.
    Yang R; Xu J; Xu L; Sun X; Chen Q; Zhao Y; Peng R; Liu Z
    ACS Nano; 2018 Jun; 12(6):5121-5129. PubMed ID: 29771487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathione-depletion mesoporous organosilica nanoparticles as a self-adjuvant and Co-delivery platform for enhanced cancer immunotherapy.
    Lu Y; Yang Y; Gu Z; Zhang J; Song H; Xiang G; Yu C
    Biomaterials; 2018 Aug; 175():82-92. PubMed ID: 29803106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.